SCHEMBL4037898

SCHEMBL4037898

O=C(NC1CCC(F)(F)CC1)[C@@H](C1CCCCC1)C1(c2ccc(Cl)cc2)Nc2ccccc2N1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 4/20 0.51
CNR1 P21554 4/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
EPHX1 P07099 3/20 0.37
ALDH1A1 P00352 2/20 0.37
POLB P06746 1/20 0.37
NPC1 O15118 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
RAB9A P51151 1/20 0.37
ACKR3 P25106 1/20 0.36
TSHR P16473 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4034388 1.00 NR1H4 (0.51) NR1H4CNR1SMN1; SMN2EPHX1ALDH1A1
SCHEMBL4039101 0.92 NR1H4 (0.44) NR1H4SMN1; SMN2EPHX1ALDH1A1POLB
SCHEMBL4044540 0.92 NR1H4 (0.44) NR1H4SMN1; SMN2EPHX1ALDH1A1POLB
SCHEMBL4042732 0.92 NR1H4 (0.44) NR1H4SMN1; SMN2EPHX1ALDH1A1POLB
SCHEMBL4040480 0.92 NR1H4 (0.44) NR1H4SMN1; SMN2EPHX1ALDH1A1POLB
SCHEMBL4039448 0.88 NR1H4 (0.48) NR1H4SMN1; SMN2EPHX1ALDH1A1POLB
SCHEMBL4039874 0.88 NR1H4 (0.48) NR1H4SMN1; SMN2EPHX1ALDH1A1POLB
SCHEMBL4041029 0.87 NR1H4 (0.49) NR1H4SMN1; SMN2EPHX1ALDH1A1POLB
SCHEMBL4040912 0.87 NR1H4 (0.49) NR1H4SMN1; SMN2EPHX1ALDH1A1POLB
SCHEMBL4036666 0.84 RAB9A (0.42) NR1H4SMN1; SMN2EPHX1ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP claimed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO claimed
EP-3043865-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) 2016-07-20 EP disclosed
WO-2015036442-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2015-03-19 WO disclosed
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed